Market Overview:
The global polyaspartic floor coating market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for floor coatings in hospitals, clinics, and recovery centers. In terms of type, the 1mg/pill segment is expected to lead the global polyaspartic floor coating market during the forecast period. This can be attributed to its low price and easy availability as compared to other types of polyaspartic floor coatings.
Product Definition:
Polyaspartic floor coating is a two-component, waterborne polyurethane coating that dries quickly to form a durable, abrasion and chemical resistant finish. It can be used on concrete floors in industrial and commercial settings. Polyaspartic floor coatings are important because they provide a tough, durable finish that can stand up to heavy traffic and exposure to chemicals.
1mg/pill:
1mg/pill is a micro-sized particle of polyaspartic floor coating, which is used to cover the entire area of one square meter. It has a uniform and homogenous surface due to its highly porous structure. The 1mg/pill particles are coated with shellac and are then bound together in pellets by using an adhesive.
5mg/pill:
5mg/pill is a high strength prescription pain relievers, which is used to treat chronic pain. It’s an opioid based drug and works by attaching to receptors in the brain, which then blocks them to reduce or eliminate the pain.
The U.S has witnessed an alarming increase in deaths caused due to opioids overdose; this includes both synthetic and natural opioids such as heroin and fentanyl.
Application Insights:
The market is segmented on the basis of application into hospital, clinic and recovery center. The hospital segment dominated the overall industry in terms of revenue share in 2017. This high share is attributable to increasing government funding for the construction of hospitals across various regions coupled with a rise in number of hospitalized patients due to COVID-19 pandemic.
Polyaspartic acid floor coating has excellent antibacterial properties, which help prevent spread of infection caused by bacteria including Staphylococcus aureus, Escherichia coli O157:H7 and Klebsiella pneumoniae among others. These factors are likely to increase product demand from 2018 as healthcare infrastructure suffers from shortage of staff and resources owing to COVID-19 pandemic situation across all major regions globally.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is anticipated to continue its dominance over the forecast period. The growth of this region can be attributed to rising product demand from various end-use industries, such as healthcare, education, offices & meeting rooms, hotels & restaurants. Increasing construction activities due to growing urbanization are also expected to drive product demand in this region.
The recovery of the construction industry after recession caused by pandemic COVID-19 is expected favorably impact overall economic growth in North America and Europe which would result into increased investments for new constructions including hospitals and clinics thereby driving polyaspartic floor coating market over the forecast period. In addition, increasing foreign direct investments coupled with favorable government policies aimed at promoting manufacturing output would fuel industrial production leading to an increase in polyaspartic floor coatings consumption across countries such as Germany and France thus positively impacting overall industry growth across regions globally.
Growth Factors:
- Increasing demand for floor coatings in the automotive and construction industries due to their durability and resistance to wear and tear.
- Rising awareness about the benefits of polyaspartic floor coatings among consumers, which is resulting in an increase in their demand.
- The increasing popularity of DIY projects, which is helping to boost the sales of polyaspartic floor coatings products.
- Growing investments by leading players in research and development activities to develop new and innovative products that can cater to the needs of consumers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polyaspartic Floor Coating Market Research Report
By Type
1mg/pill, 5mg/pill, 10mg/pill, 20mg/pill
By Application
Hospital, Clinic, Recovery Center
By Companies
Hikma, Par Pharmaceutical, Teva, Cadista, Xianju Pharma, Henan Lihua Pharmaceutical, Tianjin Jinjin Pharmaceutical, Hayao Group, Xian Lijun Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Polyaspartic Floor Coating Market Report Segments:
The global Polyaspartic Floor Coating market is segmented on the basis of:
Types
1mg/pill, 5mg/pill, 10mg/pill, 20mg/pill
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hikma
- Par Pharmaceutical
- Teva
- Cadista
- Xianju Pharma
- Henan Lihua Pharmaceutical
- Tianjin Jinjin Pharmaceutical
- Hayao Group
- Xian Lijun Pharmaceutical
Highlights of The Polyaspartic Floor Coating Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1mg/pill
- 5mg/pill
- 10mg/pill
- 20mg/pill
- By Application:
- Hospital
- Clinic
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polyaspartic Floor Coating Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polyaspartic floor coating is a type of floor finish that is made up of small, uniform particles. These particles are typically made from polymers and fillers, and they are combined with a solvent to create the finished product. Polyaspartic coatings are often used on floors because they provide a smooth surface that is easy to clean. They also have good resistance to water and oil stains, which makes them ideal for use in areas where there is heavy foot traffic or spills.
Some of the major companies in the polyaspartic floor coating market are Hikma, Par Pharmaceutical, Teva, Cadista, Xianju Pharma, Henan Lihua Pharmaceutical, Tianjin Jinjin Pharmaceutical, Hayao Group, Xian Lijun Pharmaceutical.
The polyaspartic floor coating market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polyaspartic Floor Coating Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Polyaspartic Floor Coating Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Polyaspartic Floor Coating Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Polyaspartic Floor Coating Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Polyaspartic Floor Coating Market Size & Forecast, 2020-2028
4.5.1 Polyaspartic Floor Coating Market Size and Y-o-Y Growth
4.5.2 Polyaspartic Floor Coating Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1mg/pill
5.2.2 5mg/pill
5.2.3 10mg/pill
5.2.4 20mg/pill
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polyaspartic Floor Coating Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polyaspartic Floor Coating Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1mg/pill
9.6.2 5mg/pill
9.6.3 10mg/pill
9.6.4 20mg/pill
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1mg/pill
10.6.2 5mg/pill
10.6.3 10mg/pill
10.6.4 20mg/pill
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1mg/pill
11.6.2 5mg/pill
11.6.3 10mg/pill
11.6.4 20mg/pill
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1mg/pill
12.6.2 5mg/pill
12.6.3 10mg/pill
12.6.4 20mg/pill
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1mg/pill
13.6.2 5mg/pill
13.6.3 10mg/pill
13.6.4 20mg/pill
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polyaspartic Floor Coating Market: Competitive Dashboard
14.2 Global Polyaspartic Floor Coating Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hikma
14.3.2 Par Pharmaceutical
14.3.3 Teva
14.3.4 Cadista
14.3.5 Xianju Pharma
14.3.6 Henan Lihua Pharmaceutical
14.3.7 Tianjin Jinjin Pharmaceutical
14.3.8 Hayao Group
14.3.9 Xian Lijun Pharmaceutical
